Breast, bladder, and prostate cancers were dominated by one index feature: lump (14,200/15,662, 91·0%), raised prostate-specific antigen (14,473/22,270, 65·0%), and visible haematuria (3435/5346, 64·3%), respectively (Table 3). This evidence concerns the gene KLK3 and prostate cancer.